Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 Sep;37(9):1982–1985. doi: 10.1128/aac.37.9.1982

Bleomycin increases amikacin and streptomycin resistance in Escherichia coli harboring transposon Tn5.

J Blazquez 1, J L Martinez 1, F Baquero 1
PMCID: PMC188104  PMID: 7694544

Abstract

The antitumor antibiotic bleomycin acts as a transcriptional inducer of the neo-ble-str operon of the transposon Tn5, increasing the resistance level to streptomycin and amikacin in Tn5-containing Escherichia coli. The mechanism may involve a recA-independent induction mediated by DNA damage.

Full text

PDF
1982

Images in this article

1983Image
on p.1983

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auerswald E. A., Ludwig G., Schaller H. Structural analysis of Tn5. Cold Spring Harb Symp Quant Biol. 1981;45(Pt 1):107–113. doi: 10.1101/sqb.1981.045.01.019. [DOI] [PubMed] [Google Scholar]
  2. Berg D. E., Davies J., Allet B., Rochaix J. D. Transposition of R factor genes to bacteriophage lambda. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3628–3632. doi: 10.1073/pnas.72.9.3628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blot M., Meyer J., Arber W. Bleomycin-resistance gene derived from the transposon Tn5 confers selective advantage to Escherichia coli K-12. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9112–9116. doi: 10.1073/pnas.88.20.9112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bolivar F., Rodriguez R. L., Greene P. J., Betlach M. C., Heyneker H. L., Boyer H. W., Crosa J. H., Falkow S. Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene. 1977;2(2):95–113. [PubMed] [Google Scholar]
  5. Casadaban M. J., Chou J., Cohen S. N. In vitro gene fusions that join an enzymatically active beta-galactosidase segment to amino-terminal fragments of exogenous proteins: Escherichia coli plasmid vectors for the detection and cloning of translational initiation signals. J Bacteriol. 1980 Aug;143(2):971–980. doi: 10.1128/jb.143.2.971-980.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Collis C. M., Hall R. M. Identification of a Tn5 determinant conferring resistance to phleomycins, bleomycins, and tallysomycins. Plasmid. 1985 Sep;14(2):143–151. doi: 10.1016/0147-619x(85)90074-5. [DOI] [PubMed] [Google Scholar]
  7. De Vos G. F., Finan T. M., Signer E. R., Walker G. C. Host-dependent transposon Tn5-mediated streptomycin resistance. J Bacteriol. 1984 Jul;159(1):395–399. doi: 10.1128/jb.159.1.395-399.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fisher L. M., Kuroda R., Sakai T. T. Interaction of bleomycin A2 with deoxyribonucleic acid: DNA unwinding and inhibition of bleomycin-induced DNA breakage by cationic thiazole amides related to bleomycin A2. Biochemistry. 1985 Jun 18;24(13):3199–3207. doi: 10.1021/bi00334a019. [DOI] [PubMed] [Google Scholar]
  9. Genilloud O., Blázquez J., Mazodier P., Moreno F. A clinical isolate of transposon Tn5 expressing streptomycin resistance in Escherichia coli. J Bacteriol. 1988 Mar;170(3):1275–1278. doi: 10.1128/jb.170.3.1275-1278.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Genilloud O., Garrido M. C., Moreno F. The transposon Tn5 carries a bleomycin-resistance determinant. Gene. 1984 Dec;32(1-2):225–233. doi: 10.1016/0378-1119(84)90050-7. [DOI] [PubMed] [Google Scholar]
  11. Hancock R. E. Aminoglycoside uptake and mode of action--with special reference to streptomycin and gentamicin. I. Antagonists and mutants. J Antimicrob Chemother. 1981 Oct;8(4):249–276. doi: 10.1093/jac/8.4.249. [DOI] [PubMed] [Google Scholar]
  12. Lown J. W., Sim S. K. The mechanism of the bleomycin-induced cleavage of DNA. Biochem Biophys Res Commun. 1977 Aug 22;77(4):1150–1157. doi: 10.1016/s0006-291x(77)80099-5. [DOI] [PubMed] [Google Scholar]
  13. Mazodier P., Cossart P., Giraud E., Gasser F. Completion of the nucleotide sequence of the central region of Tn5 confirms the presence of three resistance genes. Nucleic Acids Res. 1985 Jan 11;13(1):195–205. doi: 10.1093/nar/13.1.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mazodier P., Genilloud O., Giraud E., Gasser F. Expression of Tn5-encoded streptomycin resistance in E. coli. Mol Gen Genet. 1986 Sep;204(3):404–409. doi: 10.1007/BF00331016. [DOI] [PubMed] [Google Scholar]
  15. Perlin M. H., Lerner S. A. Decreased susceptibility to 4'-deoxy-6'-N-methylamikacin (BB-K311) conferred by a mutant plasmid in Escherichia coli. Antimicrob Agents Chemother. 1982 Jul;22(1):78–82. doi: 10.1128/aac.22.1.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Perlin M. H., Lerner S. A. High-level amikacin resistance in Escherichia coli due to phosphorylation and impaired aminoglycoside uptake. Antimicrob Agents Chemother. 1986 Feb;29(2):216–224. doi: 10.1128/aac.29.2.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Putnoky P., Kiss G. B., Ott I., Kondorosi A. Tn5 carries a streptomycin resistance determinant downstream from the kanamycin resistance gene. Mol Gen Genet. 1983;191(2):288–294. doi: 10.1007/BF00334828. [DOI] [PubMed] [Google Scholar]
  18. Rothstein S. J., Reznikoff W. S. The functional differences in the inverted repeats of Tn5 are caused by a single base pair nonhomology. Cell. 1981 Jan;23(1):191–199. doi: 10.1016/0092-8674(81)90284-1. [DOI] [PubMed] [Google Scholar]
  19. Walker G. C. Mutagenesis and inducible responses to deoxyribonucleic acid damage in Escherichia coli. Microbiol Rev. 1984 Mar;48(1):60–93. doi: 10.1128/mr.48.1.60-93.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES